The Radboud University Medical Centre (RUMC) support the consortium leading the pharmacokinetic sub-studies to assess the drug interactions of antiretrovirals and the tuberculosis treatment and to understand rates of efficacy and toxicity of empirical valganciclovir treatment in infants”. They have conducted many other PK studies with antiretroviral agents in African countries (i.a. CHAPAS1-4 and Odyssey).
The Radboud University Medical Centre (RUMC), and its Pharmacology of antiviral drugs group, is one of the leading centres in pharmacokinetics (PK) studies focus in treatment of HIV in special patient population such as children. The department of Pharmacy of the RUMC is located in Nijmegen, The Netherlands. Their main focus is on clinical pharmacology of antimicrobial agents (HIV, TB, antifungal agents and HCV) within the RUMC research group Infectious diseases and global health.